Sharp decrease in BLFS’s short interest leads to decline in days-to-cover ratio

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Biolife Solutions Inc shares valued at $21,410,325 were purchased by Casdin Partners Master Fund, L on Oct 15 ’25. At $28.55 per share, Casdin Partners Master Fund, L acquired 750,000 shares.

Also, Wichterman Troy sold 833 shares, netting a total of over 22,791 in proceeds. Following the sale of shares at $27.36 each, the insider now holds 183,353 shares.

Before that, Berard Todd had sold 289 shares from its account. In a trade valued at $7,907, the Chief Marketing Officer traded Biolife Solutions Inc shares for $27.36 each. Upon closing the transaction, the insider’s holdings decreased to 289 shares, worth approximately $3.84 million.

Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of April 04, 2024, Jefferies has initiated its “Buy” rating for BLFS. Earlier on July 11, 2023, Craig Hallum initiated its rating. Their recommendation was “a Buy” for BLFS stock.

Analyzing BLFS Stock Performance

On last trading session, Biolife Solutions Inc [NASDAQ: BLFS] rose 3.94% to $28.75. The stock’s lowest price that day was $27.86, but it reached a high of $28.945 in the same session. During the last five days, there has been a surge of approximately 5.16%. Over the course of the year, Biolife Solutions Inc shares have jumped approximately 27.21%.

Is Biolife Solutions Inc subject to short interest?

Stocks of Biolife Solutions Inc saw a sharp steep in short interest on 2025-09-30 dropping by -0.26 million shares to 3.69 million. Data from Yahoo Finance shows that the short interest on 2025-08-29 was 3.94 million shares. A decline of -6.93% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.92 of the overall float, the days-to-cover ratio (short ratio) decline to 9.92.

Which companies own the most shares of Biolife Solutions Inc (BLFS)?

In terms of Biolife Solutions Inc share price expectations, FactSet research, analysts set an average price target of 30 in the next 12 months, up nearly 8.46% from the previous closing price of $27.66. Analysts anticipate Biolife Solutions Inc stock to reach 30 by 2025, with the lowest price target being 22. In spite of this, 4 analysts ranked Biolife Solutions Inc stock as Buy at the end of 2025. On April 25, 2022, Oppenheimer assigned a price target of “an Outperform” to the stock and upgraded coverage with a $28.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.